Up a level |
Number of items: 1.
Erdmann, E., Harding, S., Lam, H. and Perez, A. (2016). Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes. Diabetes Obes. Metab., 18 (3). S. 266 - 274. HOBOKEN: WILEY. ISSN 1463-1326